EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.1.36 | - |
Homo sapiens |
2.7.1.36 | - |
Rattus norvegicus |
2.7.1.36 | expressed in Escherichia coli BL21(DE3) | Staphylococcus aureus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.36 | 5-phosphomevalonate | product inhibition, non-competitive with ATP and mevalonate | Staphylococcus aureus | |
2.7.1.36 | farnesyl diphosphate | feedback inhibition, competitive with ATP | Homo sapiens | |
2.7.1.36 | farnesyl diphosphate | feedback inhibition, competitive with ATP | Rattus norvegicus | |
2.7.1.36 | farnesyl diphosphate | feedback inhibition, competitive with ATP | Staphylococcus aureus | |
2.7.1.36 | farnesyl thiodiphosphate | feedback inhibition, competitive with ATP | Homo sapiens | |
2.7.1.36 | farnesyl thiodiphosphate | feedback inhibition, competitive with ATP | Rattus norvegicus | |
2.7.1.36 | farnesyl thiodiphosphate | feedback inhibition, competitive with ATP | Staphylococcus aureus | |
2.7.1.36 | mevalonate | substrate inhibition at millimolar concentrations, 50% inhibition at 2.88 mM | Staphylococcus aureus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.1.36 | 0.041 | - |
R,S-mevalonate | pH 7.5, 30°C | Staphylococcus aureus | |
2.7.1.36 | 0.339 | - |
ATP | pH 7.5, 30°C | Staphylococcus aureus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.7.1.36 | cytosol | - |
Staphylococcus aureus | 5829 | - |
2.7.1.36 | cytosol | - |
Homo sapiens | 5829 | - |
2.7.1.36 | cytosol | - |
Rattus norvegicus | 5829 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.36 | Mg2+ | required | Staphylococcus aureus | |
2.7.1.36 | Mn2+ | 25% of the activity with Mg2+ | Staphylococcus aureus |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 33000 | - |
1 * 33000, SDS-PAGE and gel filtration | Staphylococcus aureus |
2.7.1.36 | 34500 | - |
gel filtration | Staphylococcus aureus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.36 | ATP + (R)-mevalonate | Rattus norvegicus | involved in cholesterol synthesis | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | Homo sapiens | involved in cholesterol synthesis, decreased enzyme activity involved in mevalonic aciduria and hyperimmunoglobulin D syndrome | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | Staphylococcus aureus | involved in isopentenyl diphosphate synthesis | ADP + (R)-5-phosphomevalonate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.36 | Homo sapiens | - |
- |
- |
2.7.1.36 | Rattus norvegicus | - |
- |
- |
2.7.1.36 | Staphylococcus aureus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.1.36 | recombinant enzyme | Staphylococcus aureus |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 12.4 | - |
purified enzyme, pH 7.5, 30°C | Staphylococcus aureus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.36 | ATP + (R)-mevalonate | - |
Staphylococcus aureus | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | - |
Homo sapiens | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | - |
Rattus norvegicus | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | involved in cholesterol synthesis | Rattus norvegicus | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | involved in cholesterol synthesis, decreased enzyme activity involved in mevalonic aciduria and hyperimmunoglobulin D syndrome | Homo sapiens | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + (R)-mevalonate | involved in isopentenyl diphosphate synthesis | Staphylococcus aureus | ADP + (R)-5-phosphomevalonate | - |
? | |
2.7.1.36 | ATP + mevalonate | - |
Staphylococcus aureus | ADP + phosphomevalonate | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.7.1.36 | monomer | 1 * 33000, SDS-PAGE and gel filtration | Staphylococcus aureus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 7 | 8.5 | - |
Staphylococcus aureus |
EC Number | pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|---|
2.7.1.36 | 6 | 9 | - |
Staphylococcus aureus |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.1.36 | 0.000029 | - |
farnesyl thiodiphosphate | pH 7.5, 30°C | Homo sapiens | |
2.7.1.36 | 0.000035 | - |
farnesyl diphosphate | pH 7.5, 30°C | Homo sapiens | |
2.7.1.36 | 0.00035 | - |
farnesyl diphosphate | pH 7.5, 30°C | Rattus norvegicus | |
2.7.1.36 | 0.00047 | - |
farnesyl thiodiphosphate | pH 7.5, 30°C | Rattus norvegicus | |
2.7.1.36 | 0.045 | - |
farnesyl thiodiphosphate | pH 7.5, 30°C | Staphylococcus aureus | |
2.7.1.36 | 0.046 | - |
farnesyl diphosphate | pH 7.5, 30°C | Staphylococcus aureus |